Tu1687 Sofosbuvir Plus Ribavirin for 12 Weeks in Genotype 2 HCV Compensated Cirrhotic Patients; A Comparative Analysis of VALOR-HCV SVR Data to Registration Trials and Real World Cohorts
Publication/Presentation Date
4-2016
Volume
150
Issue
4
Published In/Presented At
Disciplines
Medicine and Health Sciences
Department(s)
Department of Medicine
Document Type
Article
COinS
